Products for the Future

DENALI selects candidates for nutraceutical development based on the quality of ethnomedicinal documentation and correlation of traditional uses with overall good health or alleviation of various health problems. This ethnomedicinal information is corroborated with extensive in-house research, independent laboratory evaluations and comparisons, and further substantiation with data in the scientific literature. We have identified scientific evidence that demonstrates Alaska Natives' historical relative freedom from chronic conditions such as cardiovascular disease, diabetes and complications, and cancer, and the traditional knowledge they possess for management of pain, and acute conditions such as injury and infection.

The Company is committed to developing and commercializing products that are based on prolific source plants or those harvested by a sustainable process. The principal component of our flagship product, AuroraBlue, is a Vaccinium species considered by some to be an invasive weed. The same is true of the dandelions used in AuroraGreen. Although the source plants for rosehips used in AuroraRed are not considered to be weeds, they grow vigorously in the wild throughout all of Alaska. We work closely with Alaska Native groups that provide counsel and harvesters for our current and future products. Their participation is essential for DENALI's success, and for health and well-being of their communities and our customers.